Onyx Pharmaceuticals, Inc. (NASDAQ:ONXX)

CAPS Rating: 3 out of 5

A biopharmaceutical company building an oncology business by developing and commercializing innovative therapies that target the molecular mechanisms implicated in cancer.

Recs

0
Player Avatar mizims (33.39) Submitted: 10/27/2009 2:36:05 AM : Outperform Start Price: $25.26 ONXX Score: +61.85

my be a bore in the short term, but long term it will be a winner

Featured Broker Partners


Advertisement